News

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
South Africa’s government has estimated that universities and science councils could lose about $107 million in U.S. research ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.
There are over 100,000 HIV+ Texans. Trump's 'big beautiful' bill would slash funding for federal HIV prevention, medications, ...
A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...
The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...
A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.
Rep. Marjorie Taylor Greene (R-GA) ranted about how the U.S. sends money to Africa to prevent the spread of HIV, arguing that ...
The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...
Global Fund aims for the first shipment to reach at least one African country by year-end. Read more at straitstimes.com.
The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...